查看购物车
  • Traditional Chinese
  • English
  • Japanese
胚胎着床前基因检测市场规模、份额和成长分析（按检测类型、技术、类别、最终用户和地区划分）—产业预测，2025-2032年
市场调查报告书
商品编码
1865216

胚胎着床前基因检测市场规模、份额和成长分析（按检测类型、技术、类别、最终用户和地区划分）—产业预测，2025-2032年

Preimplantation Genetic Testing Market Size, Share, and Growth Analysis, By Test Type, By Technology, By Category, By End-User, By Region - Industry Forecast 2025-2032
出版日期: | 出版商: SkyQuest | 英文 185 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全球胚胎着床前基因检测市场规模预计在 2023 年达到 8.775 亿美元，从 2024 年的 9.4331 亿美元增长到 2032 年的 16.8238 亿美元，在预测期（2025-2032 年）内复合年增长率为 7.5%。

市场分析显示，胚胎胚胎着床前基因检测需求的成长主要受以下因素驱动：遗传疾病的增加、不孕症发生率的上升、基因筛检技术的进步以及体外受精（IVF）基础设施的扩展。遗传异常的高发生率推动了早期基因检测的普及，而与生活方式和环境因素相关的不孕症发病率上升则推动了对IVF解决方案的需求。胚胎着床前基因检测已成为生殖医学的重要组成部分，因为它能提高IVF的成功率并减少所需的治疗週期数。此外，公众对遗传疾病和孕产妇健康的日益关注也推动了市场成长。然而，高昂的治疗费用、伦理问题、人力资源短缺以及临床结果的不确定性等挑战可能会阻碍未来的市场渗透。

全球胚胎着床前基因检测市场驱动因素

全球胚胎着床前遗传学检测市场正经历显着成长，这主要得益于全球试管婴儿中心、生育诊所和专业诊断实验室的激增，从而推高了对这类检测服务的需求。此外，尤其是在发展中地区，对改善生殖健康基础设施的大量投资也为胚胎着床前遗传学检测服务提供者开闢了新的机会。生育服务基础设施的扩建是推动市场发展的关键因素，因为它提高了基因检测的可及性和认知度，最终为全球胚胎胚胎着床前遗传学检测产业带来了光明的前景。

限制全球胚胎着床前基因检测市场的因素

全球胚胎着床前遗传学检测市场面临严峻挑战，因为这些检测项目费用高昂，并显着增加了体外受精（IVF）的总成本。这种经济负担可能会使许多夫妇，尤其是经济条件较差的夫妇，放弃选择这项治疗方案。高昂的费用主要源自于对先进技术、一流实验室基础设施和专业人才的需求。此外，缺乏保险覆盖也加剧了这个问题，进一步限制了中低收入者获得这项服务的机会，并阻碍了胚胎着床前遗传学检测的广泛应用。

全球胚胎着床前基因检测市场趋势

全球胚胎着床前遗传学检测市场正加速向非侵入性遗传学检测方法转型，这主要得益于消费者对更安全、更微创的检测方式日益增长的需求。利用分析胚胎培养液中游离DNA的技术创新，无需进行传统的胚胎细胞萃取，从而最大限度地减少了对胚胎的潜在损伤。这项进步不仅提高了检测过程的安全性和可行性，也符合消费者对微创医疗程序的日益增长的偏好。因此，随着这些先进调查方法的应用，预计市场将显着成长。

目录

介绍

  • 调查目标
  • 调查范围
  • 定义

调查方法

  • 资讯收集
  • 二手资料和一手资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分市场机会分析

市场动态与展望

  • 市场概览
  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 关键投资机会
  • 市场生态系统
  • 市场吸引力指数（2024）
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析
  • 技术评估
  • 监管环境

全球胚胎着床前基因检测市场规模（依检测类型划分）、复合年增长率（2025-2032 年）

  • 市场概览
  • 胚胎着床前遗传学诊断（PGD）
  • 胚胎着床前遗传学筛检（PGS）/非整倍筛检
  • HLA型检测/胚胎配对
  • 其他的

全球胚胎着床前基因检测市场规模（依技术划分）、复合年增长率（2025-2032 年）

  • 市场概览
  • 次世代定序（NGS）
  • 聚合酵素链锁反应（PCR）
  • 萤光原位杂合反应（FISH）
  • 比较基因组杂合反应/微阵列
  • 单核苷酸多态性（SNP）和基于人工智慧的平台

全球胚胎着床前基因检测市场规模（按类别划分）、复合年增长率（2025-2032 年）

  • 市场概览
  • 试剂和耗材
  • 设备/平台
  • 软体和生物资讯学服务

全球胚胎着床前基因检测市场规模（以最终用户划分），复合年增长率（2025-2032 年）

  • 市场概览
  • 不孕症诊所/试管婴儿中心
  • 医院和辅助生殖技术（ART）中心
  • 诊断实验室

全球胚胎着床前基因检测市场规模（按地区划分）、复合年增长率（2025-2032 年）

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业的市场定位（2024 年）
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市占率分析（2024 年）
  • 主要企业公司简介
    • 公司详情
    • 产品系列分析
    • 依业务板块进行公司股票分析
    • 2022-2024年营收年比比较

主要企业简介

  • Illumina Inc.
  • Thermo Fisher Scientific Inc.
  • PerkinElmer Inc.
  • CooperSurgical Inc.
  • Abbott Laboratories
  • Natera Inc.
  • Genea Limited
  • Roche Holding AG
  • Agilent Technologies Inc.
  • Labcorp Holdings Inc.
  • Invitae Corp.
  • Oxford Gene Technology IP
  • Yikon Genomics
  • Bioarray SL
  • Genesis Genetics
  • Fulgent Genetics
  • Igenomix
  • Vitrolife AB
  • MedGenome Labs
  • CombiMatrix Corporation

结论与建议

简介目录
Product Code: SQMIG35D2364

Global Preimplantation Genetic Testing Market size was valued at USD 877.5 million in 2023 and is poised to grow from USD 943.31 million in 2024 to USD 1682.38 million by 2032, growing at a CAGR of 7.5% during the forecast period (2025-2032).

Market insights indicate that the demand for preimplantation genetic testing is significantly driven by the increasing prevalence of genetic disorders, the rising rates of infertility, and advancements in genetic screening technologies, alongside the expansion of IVF infrastructure. The high incidence of genetic abnormalities fosters the adoption of early genetic testing, while rising infertility is linked to lifestyle factors and environmental influences, amplifying the need for IVF solutions. Preimplantation genetic testing enhances IVF success rates and reduces the number of cycles needed, becoming essential in reproductive health. Additionally, growing public awareness about genetic diseases and maternal health promotes market growth. However, challenges such as high procedure costs, ethical concerns, workforce shortages, and uncertainties in clinical outcomes could hinder market penetration going forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Preimplantation Genetic Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Preimplantation Genetic Testing Market Segments Analysis

Global Preimplantation Genetic Testing Market is segmented by Test Type, Technology, Category, End-User and region. Based on Test Type, the market is segmented into Preimplantation Genetic Diagnosis (PGD), Preimplantation Genetic Screening (PGS) / Aneuploidy Screening, HLA Typing / Embryo Matching and Others. Based on Technology, the market is segmented into Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence In-Situ Hybridization (FISH), Comparative Genomic Hybridization / Microarray and Single-Nucleotide Polymorphism (SNP) & AI-based Platforms. Based on Category, the market is segmented into Reagents & Consumables, Instruments / Platforms and Software & Bioinformatics Services. Based on End-User, the market is segmented into Fertility Clinics / IVF Centres, Hospitals & Assisted Reproductive Technology (ART) Centres and Diagnostic Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Preimplantation Genetic Testing Market

The global preimplantation genetic testing market is experiencing significant growth due to the surge in the number of IVF centers, fertility clinics, and specialized diagnostic laboratories worldwide, which enhances the demand for these testing services. Additionally, substantial investments aimed at improving reproductive healthcare infrastructure, particularly in developing regions, are opening new avenues for preimplantation genetic testing providers. This expansion in fertility service infrastructure is a key factor propelling the market forward, as it increases accessibility and awareness of genetic testing options, ultimately leading to a brighter outlook for the preimplantation genetic testing industry on a global scale.

Restraints in the Global Preimplantation Genetic Testing Market

The global preimplantation genetic testing market faces significant challenges due to the high costs associated with these procedures, which considerably increase the overall expenses of in vitro fertilization (IVF). This financial burden can discourage many couples, particularly those with limited financial means, from pursuing such options. The elevated costs are primarily a result of the need for advanced technology, state-of-the-art laboratory infrastructure, and specialized expertise. Additionally, the absence of reimbursement options exacerbates the issue, further limiting access for individuals in low- and middle-income regions, thus hindering wider adoption of preimplantation genetic testing.

Market Trends of the Global Preimplantation Genetic Testing Market

The Global Preimplantation Genetic Testing market is increasingly witnessing a shift towards non-invasive genetic testing approaches, driven by the rising demand for safer, minimally invasive procedures. Innovations in techniques for analyzing cell-free DNA from spent embryo culture media are transforming traditional methods by eliminating the need for embryo cell extraction, thereby minimizing potential damage to embryos. This advancement not only enhances the safety and viability of the testing process but also aligns with growing consumer preferences for less invasive medical practices. As a result, the market is poised for significant growth with the adoption of these progressive methodologies.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technology Assessment
  • Regulatory Landscape

Global Preimplantation Genetic Testing Market Size by Test Type & CAGR (2025-2032)

  • Market Overview
  • Preimplantation Genetic Diagnosis (PGD)
  • Preimplantation Genetic Screening (PGS) / Aneuploidy Screening
  • HLA Typing / Embryo Matching
  • Others

Global Preimplantation Genetic Testing Market Size by Technology & CAGR (2025-2032)

  • Market Overview
  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Fluorescence In-Situ Hybridization (FISH)
  • Comparative Genomic Hybridization / Microarray
  • Single-Nucleotide Polymorphism (SNP) & AI-based Platforms

Global Preimplantation Genetic Testing Market Size by Category & CAGR (2025-2032)

  • Market Overview
  • Reagents & Consumables
  • Instruments / Platforms
  • Software & Bioinformatics Services

Global Preimplantation Genetic Testing Market Size by End-User & CAGR (2025-2032)

  • Market Overview
  • Fertility Clinics / IVF Centres
  • Hospitals & Assisted Reproductive Technology (ART) Centres
  • Diagnostic Laboratories

Global Preimplantation Genetic Testing Market Size & CAGR (2025-2032)

  • North America (Test Type, Technology, Category, End-User)
    • US
    • Canada
  • Europe (Test Type, Technology, Category, End-User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Test Type, Technology, Category, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Test Type, Technology, Category, End-User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Test Type, Technology, Category, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Illumina Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CooperSurgical Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Natera Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Genea Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Holding AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Labcorp Holdings Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Invitae Corp.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Oxford Gene Technology IP
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Yikon Genomics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bioarray S.L.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Genesis Genetics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fulgent Genetics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Igenomix
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vitrolife AB
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MedGenome Labs
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CombiMatrix Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations